Indeed, cAMP-enhancing drugs: isoprenaline (beta-adrenergic receptor agonist) or forskolin, (AC8 activator), have been found to reduce the basal Ca2+ levels, SK3 channel activity, and SK3-Orai1 complex formation in breast cancer cells. Here, ORAI1 is linked to breast carcinoma.